DENTSPLY Sirona Faces Class Action Over Patient Safety and Investor Misleading Claims

DENTSPLY Sirona Faces Allegations Over Patient Safety and Misleading Information

DENTSPLY Sirona Inc., a leading manufacturer of professional dental products, is embroiled in a class action lawsuit initiated by Rosen Law Firm on behalf of shareholders who purchased common stock between May 6, 2021, and November 6, 2024. The lawsuit alleges that the company misled investors regarding its Byte aligners, which are purportedly linked to serious patient injuries. Accusations center around the company's failure to disclose critical safety information and the existence of backlogged injury reports submitted to the U.S. Food and Drug Administration (FDA) throughout 2024. These alleged omissions raise concerns about the integrity of the company’s communications and operational practices.

The lawsuit claims that DENTSPLY Sirona's internal incentives for customer service employees and affiliated dentists incentivized the enrollment of patients who should not have qualified for Byte treatment due to pre-existing dental conditions. This practice is said to have resulted in misleading representations regarding patient experiences and the oversight provided by dentists. As the truth surrounding these practices emerged, investors reportedly faced significant financial losses, prompting the need for legal recourse to recover damages. This situation underscores the potential risks associated with corporate governance and the need for transparent communication regarding patient safety.

In response to the allegations, shareholders interested in participating as lead plaintiffs must file their motions by January 27, 2025. While participation in the lawsuit is not mandatory for potential recovery, those who do not join the action can still be considered absent class members eligible for damages. Rosen Law Firm operates on a contingency fee basis, ensuring that shareholders incur no fees unless they recover damages—a model that has enabled the firm to recover over $1 billion for investors since its inception.

DENTSPLY Sirona's ongoing challenges highlight the critical importance of corporate accountability and transparent communication in the healthcare sector. As the company navigates this legal landscape, stakeholders remain vigilant about the implications for patient safety and investor rights. The resolution of this lawsuit could significantly impact DENTSPLY Sirona's reputation and operational practices moving forward.